Citation: bozso et al.Long-term outcomes following mechanical or bioprosthetic aortic valve replacement in young women.Cjc open.2020 jun 30;2(6):514-521.Doi: 10.1016/j.Cjco.2020.06.015.Ecollection 2020 nov.Earliest date of publish used for date of event.Medtronic products referenced: freestyle (pma# p970031, product code lwr), mosaic (pma# p990064, product code dye).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding long-term outcomes following mechanical or bioprosthetic aortic valve replacement in women less than 50 years old.All data were collected from the alberta provincial project for outcome assessment in coronary heart disease (approach) database between january 1, 2004, and september 16, 2018.The study population included 162 patients (female, mean age 39 years).Of those, 24 patients were implanted with a medtronic freestyle (n=23) or mosaic (n=1) bioprosthetic valve.No unique device identifier numbers were provided.Of the 162 patients, 114 were then propensity-matched for further analysis.Among all patients who received a bioprosthetic valve, 5 deaths occurred which included no deaths within 30 days, one death within one year, and four deaths beyond one year.No further details were provided on these deaths.Based on the available information medtronic product was not directly associated with the death(s).Among all patients who received a bioprosthetic valve, adverse events included: new-onset atrial fibrillation, new permanent pacemaker, sepsis, cardiac arrest, stroke, congestive heart failure, intracranial bleeding requiring hospitalization, and structural valve degeneration requiring repeat aortic valve replacement.Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
|